BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 33619642)

  • 1. Enhanced asymmetric blocked qPCR method for affordable detection of point mutations in KRAS oncogene.
    Lázaro A; Tortajada-Genaro LA; Maquieira Á
    Anal Bioanal Chem; 2021 May; 413(11):2961-2969. PubMed ID: 33619642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations.
    Huang JF; Zeng DZ; Duan GJ; Shi Y; Deng GH; Xia H; Xu HQ; Zhao N; Fu WL; Huang Q
    PLoS One; 2015; 10(12):e0145698. PubMed ID: 26701781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
    Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
    Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients.
    Seekhuntod S; Thavarungkul P; Chaichanawongsaroj N
    PLoS One; 2016; 11(1):e0147672. PubMed ID: 26812617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate detection of KRAS, NRAS and BRAF mutations in metastatic colorectal cancers by bridged nucleic acid-clamp real-time PCR.
    Nagakubo Y; Hirotsu Y; Amemiya K; Oyama T; Mochizuki H; Omata M
    BMC Med Genomics; 2019 Nov; 12(1):162. PubMed ID: 31711486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of a novel TB-ARMS qPCR method for kras mutation detection].
    Yu L; Teng F; Jiang M; Guo J
    Sheng Wu Gong Cheng Xue Bao; 2019 May; 35(5):880-891. PubMed ID: 31223006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification.
    Itonaga M; Matsuzaki I; Warigaya K; Tamura T; Shimizu Y; Fujimoto M; Kojima F; Ichinose M; Murata S
    PLoS One; 2016; 11(3):e0151654. PubMed ID: 26999437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
    Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
    BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Multiplex Detection of 7 KRAS Mutations by Taqman Allele-Specific qPCR.
    Orue A; Rieber M
    PLoS One; 2016; 11(9):e0163070. PubMed ID: 27632281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    Riva A; BØrgesen M; Guldmann-Christensen M; Hauge Kyneb M; Voogd K; Andersen C; Epistolio S; Merlo E; Yding Wolff T; Hamilton-Dutoit S; Lorenzen J; Christensen UB; Frattini M
    PLoS One; 2017; 12(6):e0178027. PubMed ID: 28636636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Atsumi J; Hanami T; Enokida Y; Ogawa H; Delobel D; Mitani Y; Kimura Y; Soma T; Tagami M; Takase Y; Ichihara T; Takeyoshi I; Usui K; Hayashizaki Y; Shimizu K
    Oncol Rep; 2015 Jun; 33(6):2719-27. PubMed ID: 25823645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay.
    Ruiz C; Huang J; Giardina SF; Feinberg PB; Mirza AH; Bacolod MD; Soper SA; Barany F
    Hum Mutat; 2020 May; 41(5):1051-1068. PubMed ID: 31950578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild‑type blocking pcr coupled with internal competitive amplified fragment improved the detection of rare mutation of KRAS.
    Peng J; Wei K; Zhao X; Yang K; Wang H; Zhang Y; Guo M; He J; Wu H; Li Y; Zhao N; Huang Q; Fu W
    Mol Med Rep; 2017 Sep; 16(3):2726-2732. PubMed ID: 28677778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of isolated tumor cells by polymerase chain reaction-restriction fragment length polymorphism for K-ras mutations in tissue samples of 199 colorectal cancer patients.
    Dieterle CP; Conzelmann M; Linnemann U; Berger MR
    Clin Cancer Res; 2004 Jan; 10(2):641-50. PubMed ID: 14760087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of mutant alleles of the K-ras gene with minor groove binder-conjugated fluorogenic DNA probes.
    Itabashi T; Maesawa C; Uchiyama M; Higuchi T; Masuda T
    Int J Oncol; 2004 Mar; 24(3):687-96. PubMed ID: 14767554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-blocker: a simple and robust probe-free quantitative PCR assay to detect somatic mutations down to 0.1% frequency.
    Kim H; Ruby AE; Shandilya HG; Virmani AK; Rahman N; Strange CM; Huuskonen J
    Biotechniques; 2018 Oct; 65(4):205-210. PubMed ID: 30284934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
    Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzymatic on/off switch-mediated assay for KRAS hotspot point mutation detection of circulating tumor DNA.
    Wang QL; Zhou CL; Yin YF; Xiao L; Wang Y; Li K
    J Clin Lab Anal; 2020 Aug; 34(8):e23305. PubMed ID: 32207862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effective and robust genotyping using double-mismatch allele-specific quantitative PCR.
    Lefever S; Rihani A; Van der Meulen J; Pattyn F; Van Maerken T; Van Dorpe J; Hellemans J; Vandesompele J
    Sci Rep; 2019 Feb; 9(1):2150. PubMed ID: 30770838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mohamed Suhaimi NA; Foong YM; Lee DY; Phyo WM; Cima I; Lee EX; Goh WL; Lim WY; Chia KS; Kong SL; Gong M; Lim B; Hillmer AM; Koh PK; Ying JY; Tan MH
    Mol Oncol; 2015 Apr; 9(4):850-60. PubMed ID: 25605225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.